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A SEXUAL dimorphism in resting nuclei has been describedfor man and monkey
among the primates, and for several species of the orders Carnivora and Artio-
dactyla. It is based on the presence of a special chromocentre, known as the sex
chromatin, in the nuclei of females. Graham and Barr (1952) suggested that
the sex chromatin may represent heterochromatic regions of the two X-chromo-
somes that adhere to each other. This hypothesis is strengthened by the
meticulous study of chromocentres in epidermal cell nuclei by Sachs and Danon
(1956). The literature pertaining to the sex chromatin and its clinical application
in anomalies of sex development has been ably reviewed by Lennox (1956),
Davidson and Smith (1956) and Nelson (1956).
Several reports have appeared that deal with the sex chromatin of tumour
cells and these will be referred to later in the paper. The observations recorded
in the present report are a sequel to the study of sex characteristics in nuclei of
benign tumours, where the nuclei were found to be like those of normal tissues
(Moore and Barr, 1955).
MATERIALS AND METHODS
Malignant tumours were studied as they became available over a period of
time from pathology laboratories and there was no attempt to concentrate on a
particular type of tumour. The series consisted of 127 specimens that included
26 types of tumours according to histopathological diagnosis; 76 tumours were
from females and 51 were from males (Table I).
Sections that are satisfactory for purposes ofhistopathology may be unsuitable
for the study of fine nuclear detail. Consequently, the procedure that resulted
in good nuclear detail in skin biopsy specimens was followed (Moore, Graham and
Barr, 1953; Barr, 1955). Small blocks of tissue were taken from favourable
regions of surgical specimens during their gross examination in a pathology
laboratory. The specimens had been immersed in formol-alcohol for several
hours. The small blocks were fixed for 24 hours in the following solution:
formalin 20per cent, 95 per cent alcohol 35 per cent, glacial acetic acid 10 per cent,
distilled water 35 per cent. After immersion in 70per cent alcohol for 1 to 3 days,
the blocks were dehydrated, embedded in paraffin and sectioned at 5 ,. Sections
from each specimen were stained by the Feulgen method and with Harris's
haematoxylin and eosin.
Two hundred tumour cell nuclei ofeach specimen, 100 in Feulgen preparations
and 100 in sections stained with H. & E., were examined for the presence or
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absence of sex chromatin. A notation was made of nuclear structure (i.e.,
female or male morphology) in normal cells of the connective tissue stroma or
vascular walls. Finally, the least and greatest diameters of the sex chromatin
were measured with a filar micrometer eyepiece in a sample of 30 malignant cells
in each of 15 types oftumour from females and in a teratocarcinoma from a male.
TABLE I.-Incidence (per cent) of Sex Chromatin
Pathological diagnosis
Adenocarcinoma of breast
Adenocarcinoma of ovary
Granulosacelltumourofovary
Theca cell carcinoma of ovary
Adenocarcinoma of uterus
Adenocarcinoma of stomach
Adenocarcinoma of large in-
testine
Adenocarcinoma of thyroid
Adenocarcinoma of gall
bladder
Adenocarcinoma of prostate
Adenocarcinoma of pancreas
Renal cell carcinoma
Basal cell carcinoma
Squamous cell carcinoma, skin
Squamous cell carcinoma, cer-
vix
Carcinoma of urinary bladder.
Malignant melanoma
Leiomyosarcoma of uterus
Rhabdomyosarcoma of cervix
Chondrosarcoma
Neurofibrosarcoma
Endometrial sarcoma
Chorion carcinoma
Seminoma
Teratocarcinoma of testis
Teratoma (epignathus)
Average
34
72
71
72
69
54
62
Range
4-76 (17)
68-75 (5)
68-74 (2)
68-76 (2)
65-73 (2)
34-65 (3)
41-75 (19
Average Range
7 3-12 (8)
4 1-9 (8)
73 72-74 (2) . 2
66 (1)
60
64
54
18
68
22
70
54
68
73
71
74
48-83
2-84
10-34
4
4
4
6
3
(1)
(4)
(3)
(5)
3-5
2-12
2-4
(1)
(3)
(1)
(1)
(6)
(8)
- (1) . 3 2-4 (6)
- (1) . 2 1-5 (4)
69-70 (2)
(1)
67-69 (2)
(1)
- (1)
Total number of specimens:
(1)
76
3
5
2
76
2-3 (2)
(1)
(1)
(1)
51
OBSERVATIONS
(a) Nuclei ofmalignant tumours infemales
Moore, Graham and Barr (1953) and Moore and Barr (1954) found that in
152 specimens ofnormal tissues from females, a mass of sex chromatin was present
in 50 to 90 per cent of nuclei, with an average incidence of 72 per cent (Fig. 1A).
Moore and Barr (1955) found that in 65 specimens of benign tumours and related
conditions in females, the sex chromatin was present in 66 to 82 per cent ofnuclei,
with an average incidence of 74 per cent (Fig. lB). The variation in the figures
for individual specimens, within the limits noted above, is probably of technical
and interpretative origin.
The sex chromatin was present in 2 to 84 per cent ofnuclei in the 76 malignant
tumours from females in the present series (Table I, Fig. lD). In about one-
third ofthe specimens the sex chromatin occurred with a frequency lower than has
been encountered in normal tissues or benign tumours. The incidence of sex
Histogenic
classification
Glandularepithe-
lium
Non-glandular
epithelium
Melanin-forming
tissue
Muscle
Connective tissue
Embryonal and
mixed tissues
385
y
A
rK. L. MOORE AND M. L. BARR
chromatin fell within the range for normal male tissues or benign lesions in males
in about one-fifth of the malignant tumours from female hosts. In general, the
sex chromatin was present in a high percentage of nuclei in well differentiated
tumours and in a low percentage of nuclei in poorly differentiated or
undifferentiated tumours. This was especially noticeable in the adenocarcino-
(Y52) (152) (58) (65)
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(51)
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54 (9)
Y
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C. MALIGNANT TUMOURS
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FIG. 1.-Histograms illustrating the incidence of sex chromatin in normal tissues, benign
tumours and malignant tumours in mrnales and females. The percentages of nuclei with
sex chronmatin are on the abscissae and the percentages of specimens are on the ordinates.
Averages for the incidence of sex chromatin are indicated by the arrows.
mata of the breast and the squamous cell carcinomata of the cervix. There thus
appears to be aninverse relation betweenthegradeofmalignancy andtheincidence
of sex chromatin, although it was difficult to assess this accurately because of the
varied histopathological diagnoses in the entire group of specimens. The average
incidence of sex chromatin was 54 per cent, but this mean value has little
significance in view ofthe large variation in the figures from which it was derived.
Nuclei in a cutaneous carcinoma, cervical carcinoma, thyroid adenocarcinoma,
100o
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basal cell carcinoma, adenocarcinoma of colon, leiomyosarcoma of uterus and
rhabdomyosarcoma of cervix are illustrated in Fig. 2, 4 to 8 and 10 to 12.
In one-third of the specimens as many as 15 per cent of nuclei contained two
masses of chromatin that were similar in all respects to the single mass of sex
chromatin in other nuclei (Fig. 10). There were occasionally three such masses
of chromatin in a nucleus.
The mean dimensions of the sex chromatin were fairly uniform among the
specimens in which measurements were made. The average size of the sex
chromatin in these malignant tumours was 0.8 x 1.3 / as compared with 0.8 x
1-2 ,a in benign lesions and 0.7 x 1.2 , in normal tissues (Moore and Barr, 1955).
The differences are probably not significant in view ofthe error involvedin measur-
ing such a small object. Occasionally, however, a mass of sex chromatin as large
as 1 1 x 2.0 It was encountered in a malignant cell, while the largest mass of sex
chromatin that had been noted in a non-malignant cell measured 1.1 x 1-3 It.
There was no obvious relation between the size ofthe sex chromatin and the grade
of malignancy.
The recognition of sex chromatin in malignant tissues was rather more difficult
than in non-malignant tissues. This was caused in part by the greater variation
in staining properties of malignant cell nuclei and the occurrence of degenerating
cells that had to be passed over. The presence ofmultiple small nucleoli made the
identification of sex chromatin difficult occasionally in haematoxylin and eosin
preparations, since a small nucleolus adjacent to the nuclear membrane simulated
sex chromatin. This difficulty was circumvented by the use of Feulgen prepara-
tions, in which the nucleoli appeared as Feulgen-negative bodies surrounded by
rims of Feulgen-positive chromatin particles (Fig. 9). The sex chromatin was
always distinctly Feulgen-positive (Fig. 7, 8, 10 and 11). In spite ofthese factors,
the difference between the incidence of sex chromatin in the series of malignant
tumours compared with normal tissues and benign lesions (Fig. 1A, B, D) was
too large to be explicable solely on technical or observational grounds.
Normal cells in the connective tissue stroma or vascular walls had a typical
female morphology in all specimens.
(b) Nuclei ofmalignant tumours in males
Moore, Graham and Barr (1953) and Moore and Barr (1954) found that in
157 specimens of normal tissues from males, a chromatin mass simulating the sex
chromatin was present in 1 to 21 per cent of nuclei, with an average incidence of
6 per cent (Fig. 1A). Moore and Barr (1955) found that in 58 specimens ofbenign
tumours and related conditions in males, a mass simulating the sex chromatin
occurred in 2 to 18 per cent of nuclei, with an average incidence of 6 per cent
(Fig. IB).
In 50 of the 51 malignant tumours from male hosts, a chromatin mass that
might be interpreted as sex chromatin was present in 1 to 12 per cent of nuclei,
with an average incidence of 4 per cent (Table I, Fig. lc). The nuclei of normal
cells in the stromal and vascular tissue had a typical male morphology in all
specimens. Insofar as the sex chromatin is concerned, therefore, the malignant
cells did not differ from the normal cells of the host. Nuclei of a cutaneous
carcinoma and an adenocarcinoma of the colon are illustrated in Fig. 3 and 9.
The single exception was a teratocarcinoma of the testis that happened to be
included in the series. In this specimen from a 27-year-old patient, 76 per cent
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ofthe nuclei contained a mass of chromatin whose mean diameter was 0-8 x 1.3 t
and which was like the sex chromatin of female cells in all respects (Fig. 1c).
The nuclei of epithelial cells in a smear preparation from the oral mucosa and the
nuclei of Leydig cells in a fragment of normal testicular tissue that accompanied
the specimen had a typical male structure. Nuclei in tumour and oral smear
are illustrated in Fig. 13. The finding in this specimen may be considered in
conjunction with the observation on another teratoma of the testis that was
included in an earlier report (Moore and Barr, 1955), where 70 per cent of the
nuclei contained the typical female sex chromatin.
DISCUSSION
Hunter and Lennox (1954) noted that the sex characteristics of nuclei in
squamous carcinomata were like those ofthe hosts, although the nuclear irregulari-
ties of the malignant cells often made an interpretation difficult. Tavares
(1955a, b) studied the nuclei of 110 malignant tumours divided equally between
female and male hosts. The sections were stained with haematoxylin and
eosin and by the Feulgen method. Sex chromatin was present in 27 to 79 per
cent of the nuclei in specimens from females, with an average incidence of about
72 per cent. Low counts were encountered in two undifferentiated cutaneous
carcinomata. In specimens from males, sex chromatin was identified in 1 to
15 per cent of nuclei, the average being about 6 per cent. Sohval and Gaines
(1955) examined the nuclei of 198 specimens that included benign and malignant
tumours, squamous metaplasia, and inflammatory and hyperplastic lesions,
using routine sections stained with haematoxylin and eosin that had been filed
in the laboratory collection. They identified typical sex chromatin in only
one-fourth of 134 specimens from females. Sex chromatin was not identified by
these authors in 64 specimens from males, with the exception of a teratoma of
the mediastinum, which had female nuclei.
The observations reported in the present paper are in agreement with those
of Tavares, except that a low incidence of sex chromatin was found in a larger
proportion of tumours from females. The small proportion of pathological
specimens from females in which sex chromatin could be identified, as reported
by Sohval and Gaines, probably resulted from the use of routine sections stained
only with haematoxylin and eosin, as the authors themselves suggested.
Weinmann, Mayer and Marwah (1955) reported that a sex chromatin-like
particle was present with an unusually high frequency for male tissues in 11 basal
cell carcinomata from male patients. The immediate vicinity ofthe lesion seemed
to be most affected. The average incidence of a mass simulating the sex chroma-
tin was only 6 per cent in the 6 basal cell carcinomata in males that were included
in the present series. However, it was not possible to study adjacent tissue since
only small biopsy specimens of the lesions were available. Coutts and Inzunza
(1955) and Coutts, Inzunza and Coutts (1956) found a wide range (3 to 40 per cent)
for the incidence of sex chromatin in benign and malignant prostatic lesions,
on studying fresh material by phase microscopy. Unfortunately, it is not possible
to interpret these observations until data derived from phase microscopy are
available for normal cells.
The low incidence of sex chromatin that was found in about one-third of the
malignant tumoursfromfemalesinthepresent series, andthe occasionaloccurrence
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ofmore than one mass ofsex chromatin, are probably a consequence ofthe diverse
chromosomal anomalies that are known to occur in cells of many malignant
tumours. For example, sex chromatin would be lacking in a nucleus that had
lost one or both X-chromosomes through a mitotic irregularity. Similarly,
fragmentation of an X-chromosome might deprive nuclei in the subsequent cell
lineage of heterochromatic regions of two X-chromosomes that combine to form
the female sex chromatin. The study of chromocentres in epidermal cell nuclei
by Sachs and Danon (1956) indicates that altered conditions ofcellular metabolism
must also be taken into consideration, since the behaviour of heterochromatic
segments of chromosomes may be affected in various ways. The suggested rela-
tion between infrequent nuclei with sex chromatin in tumours in females and
highly malignant properties of such tumours may be worthy of further investiga-
tion. Highly malignant tumours may contain a larger proportion of cells with
chromosomal anomalies, leading to a departure from the usual nuclear structure
of female cells. Such an investigation would require the study of a fairly large
series of female tumours of a type that has a relatively simple architecture, thus
facilitating grading according to histopathological criteria of malignancy.
The report of Hunter and Lennox (1954) that 5 of 9 teratomata from males
consisted of cells with female nuclei aroused considerable interest and provoked
new hypotheses on the origin of these tumours. This observation was confirmed
by Cruickshank (1955), Levij (1955) and Tavares (1955a, b). The type of nuclear
structure, female or male, has now been recorded for 85 teratomata. They were
situated in the gonads, mediastinum and pineal body. Forty-three teratomata
in females had nuclei with female morphology. Of 42 teratomata in males, 20
had a male nuclear structure, while in 22 the nuclear structure was female.
Other than the unconfirmed reports of a relativelyhigh incidence ofsex chromatin-
like masses in some basal cell carcinomata in males (Weinmann, Meyer andMarwah
1955) and in some prostatic tumours (Coutts, Inzunza and Coutts, 1956), tumour
tissue with female nuclei in male hosts has not been described except for the
teratomata. These observations have revived the view that the origin of terato-
mata differs from that of other tumours. They may possibly be derived from
primordial germ cells, some having gone astray in their migration from the
endodermal epithelium to the gonads in the early embryo and taken up extra-
gonadal positions. These cells may undergo a reduction division as do germ
cells generally. In any event there has been recourse to haploid cells in attempts
to explain the nuclear structure of teratomata. The fusion of two haploid cells
in a process akin to fertilization (Hunter and Lennox, 1954) and parthenogenesis
of a haploid cell followed by chromosome reduplication to give diploid cells
(Tavares, 1955a, b) have been suggested as possible events leading to a proportion
of contra-sexed teratomata in males but not in females.
SUMMARY
The sex characteristics of cells of malignant tumours were studied in 127
specimens, 76 from females and 51 from males. In about one-third ofthe tumours
from female hosts the incidence of sex chromatin in the nuclei was low relative
to non-malignant tissues. Two or three masses of sex chromatin were present
occasionally in the same nucleus. These departures from the nuclear structure
of normal tissues were ascribed to various chromosomal anomalies in malignant
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cells. With the exception of a teratoma of the testis, which consisted of cells
with female nuclei, all specimens from male hosts contained male nuclei.
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EXPLANATION OF PLATES
(The magnification of all photomicrographs is X 2000. The sex chromatin is indicated by
an arrow.)
FIG. 2.-Carcinoma of skin, female. Haematoxylin and eosin stain.
FIG. 3.-Carcinoma of skin, male. Feulgen stain.
FIG. 4.-Carcinoma of cervix. Haematoxylin and eosin stain.
FIG. 5.-Carcinoma of cervix. Sex chromatin is lacking in this group of nuclei. The inci-
dence ofsex chromatin was only 10 to 35 per cent in 5 cervical carcinomata. Haematoxylin
and eosin stain.
FIG. 6.-Adenocarcinoma of thyroid, female. Haematoxylin and eosin stain.
FIG. 7.-Basal cell carcinoma of skin, female. Feulgen stain.
FIG. 8.-Adenocarcinoma of colon, female. Feulgen stain.
FIG. 9.-Adenocarcinoma of colon, male, illustrating the multiple nucleoli that are present
in nuclei of some malignant cells. Feulgen stain.
FIG. 10.-Adenocarcinoma of colon, female. Two masses of sex chromatin are present.
Feulgen stain.
FIG. 11.-Leiomyosarcoma of uterus. Feulgen stain.
FIG. 12.-Rhabdomyosarcoma of cervix. Haematoxylin and eosin stain.
FIG. 13.-Teratoma of the testis. Haematoxylin and eosin stain. Inset is a nucleus of an
epithelial cell from an oral smear of the same patient. Cresyl echt violet stain.BRITISH JOURNAL OF CANCER.
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